China Universal Asset Management »

Reneo Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $11k 6.4k 1.70
2024-06-30 $5.9k 3.9k 1.51
2024-03-31 $11k 6.4k 1.66
2023-12-31 $6.2k 3.9k 1.60

More positions owned by China Universal Asset Management

Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Alphabet Inc-cl A Common Stock (GOOGL)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Tesla Common Stock (TSLA)
Regeneron Pharmaceuticals Common Stock (REGN)
Netflix Common Stock (NFLX)
Taiwan Semiconductor-sp Adr (TSM)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Reneo Pharmaceuticals

RiverVest Venture Management
Vestal Point Capital
Shay Capital
Advisor Group Holdings

View all funds holding Reneo Pharmaceuticals